Non-opioid treatment Strontium Chloride Sr-89 Injection launched in the US for metastatic bone pain

This radiopharmaceutical, administered every 3 months, has been shown to help relieve persistent pain associated with cancer that has metastasized to bone in several multicenter placebo-controlled trials. Developmental status in the UK and EU is currently unknown.


Biospace Inc.